Curtis T. Keith
Direttore/Membro del Consiglio presso Translational Development Acquisition Corp.
Posizioni attive di Curtis T. Keith
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Translational Development Acquisition Corp.
 Translational Development Acquisition Corp. Financial ConglomeratesFinance Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Curtis T. Keith
Precedenti posizioni note di Curtis T. Keith
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | Direttore Tecnico/Scientifico/R&S | 01/01/2000 | 07/02/2008 |
| Fondatore | 01/01/2000 | 07/02/2008 |
Formazione di Curtis T. Keith
| Harvard University | Doctorate Degree |
| McGill University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Canada | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | Health Technology |
Translational Development Acquisition Corp.
Translational Development Acquisition Corp. Financial ConglomeratesFinance Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY. | Finance |
- Borsa valori
- Insiders
- Curtis T. Keith
- Esperienza
